Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
GEHC Stock Forecast 2025-2026
$73.15
Current Price
$33.33B
Market Cap
Buy 15
Hold 7
Sell 0
Wall St Analyst Ratings
Distance to GEHC Price Targets
+47.6%
To High Target of $108.00
+18.9%
To Median Target of $87.00
-0.2%
To Low Target of $73.00
GEHC Price Momentum
+0.1%
1 Week Change
-0.1%
1 Month Change
-10.5%
1 Year Change
-6.4%
Year-to-Date Change
-22.8%
From 52W High of $94.80
+26.9%
From 52W Low of $57.65
📊 TOP ANALYST CALLS
Did GEHC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if GE HealthCare is one of their latest high-conviction picks.
Latest GEHC Stock Price Targets & Analyst Predictions
Based on our analysis of 20 Wall Street analysts, GEHC has a bullish consensus with a median price target of $87.00 (ranging from $73.00 to $108.00). The overall analyst rating is Strong Buy (8.5/10). Currently trading at $73.15, the median forecast implies a 18.9% upside. This outlook is supported by 15 Buy, 7 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Graham Doyle at UBS, suggesting a 0.2% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
GEHC Analyst Ratings
15
Buy
7
Hold
0
Sell
GEHC Price Target Range
Low
$73.00
Average
$87.00
High
$108.00
Current: $73.15
Latest GEHC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for GEHC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Oct 30, 2025 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $87.00 |
| Oct 30, 2025 | Morgan Stanley | Patrick Wood | Equal-Weight | Maintains | $80.00 |
| Oct 30, 2025 | Evercore ISI Group | Vijay Kumar | Outperform | Maintains | $92.00 |
| Oct 13, 2025 | BTIG | Ryan Zimmerman | Buy | Maintains | $89.00 |
| Oct 13, 2025 | Barclays | Matt Miksic | Equal-Weight | Initiates | $86.00 |
| Oct 7, 2025 | Citigroup | Joanne Wuensch | Neutral | Downgrade | $83.00 |
| Jul 31, 2025 | Morgan Stanley | Patrick Wood | Equal-Weight | Maintains | $74.00 |
| Jul 31, 2025 | Citigroup | Joanne Wuensch | Buy | Maintains | $93.00 |
| Jul 9, 2025 | Citigroup | Joanne Wuensch | Buy | Maintains | $89.00 |
| May 6, 2025 | Morgan Stanley | Patrick Wood | Equal-Weight | Maintains | $78.00 |
| May 5, 2025 | UBS | Graham Doyle | Neutral | Upgrade | $73.00 |
| May 1, 2025 | Evercore ISI Group | Vijay Kumar | Outperform | Maintains | $85.00 |
| May 1, 2025 | Goldman Sachs | David Roman | Buy | Maintains | $82.00 |
| May 1, 2025 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $89.00 |
| Apr 30, 2025 | Citigroup | Joanne Wuensch | Buy | Maintains | $86.00 |
| Apr 23, 2025 | Piper Sandler | Overweight | Maintains | $88.00 | |
| Mar 11, 2025 | Goldman Sachs | David Roman | Buy | Upgrade | $100.00 |
| Feb 14, 2025 | Wells Fargo | Larry Biegelsen | Overweight | Maintains | $103.00 |
| Feb 13, 2025 | Citigroup | Joanne Wuensch | Buy | Maintains | $110.00 |
| Jan 8, 2025 | Jefferies | Matthew Taylor | Buy | Upgrade | $103.00 |
GE HealthCare Technologies Inc. (GEHC) Competitors
The following stocks are similar to GE HealthCare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
GEHC
GE HealthCare
mkt cap
33.30B
GE HealthCare Technologies Inc. (GEHC) Financial Data
GE HealthCare Technologies Inc. has a market capitalization of $33.33B with a P/E ratio of 15.3x. The company generates $20.25B in trailing twelve-month revenue with a 10.9% profit margin.
Revenue growth is +5.8% quarter-over-quarter, while maintaining an operating margin of +14.2% and return on equity of +24.5%.
Valuation Metrics
Market Cap
$33.33B
Enterprise Value
$40.66B
P/E Ratio
15.3x
PEG Ratio
-3.2x
Price/Sales
1.7x
Growth & Margins
Revenue Growth (YoY)
+5.8%
Gross Margin
+38.7%
Operating Margin
+14.2%
Net Margin
+10.9%
EPS Growth
-5.1%
Financial Health
Cash/Price Ratio
+12.0%
Current Ratio
1.2x
Debt/Equity
105.1x
ROE
+24.5%
ROA
+5.5%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
GE HealthCare Technologies Inc. (GEHC) Business Model
About GE HealthCare Technologies Inc.
What They Do
Develops advanced healthcare equipment and diagnostic solutions.
Business Model
The company generates revenue by designing, manufacturing, and distributing medical imaging systems, patient monitoring devices, and digital health technologies. By providing essential equipment and solutions to hospitals, clinics, and research institutions, it supports healthcare professionals in improving diagnostics and patient care.
Additional Information
GE Healthcare Technology has a strong international presence and is committed to ongoing research and development, which positions it as a leader in medical technology and innovation. Its focus on operational efficiency and patient safety enhances its value proposition within the healthcare sector.
Company Information
Sector
Healthcare
Industry
Health Information Services
Employees
53,000
CEO
Mr. Peter J. Arduini
Country
United States
IPO Year
2023
Website
www.gehealthcare.comGE HealthCare Technologies Inc. (GEHC) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Why GE HealthCare Technologies (GEHC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Nov 13, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Zacks Style Scores provide investors with a tool to identify top-rated stocks tailored to their specific investing styles.
Why It Matters
Zacks Style Scores can help investors identify high-potential stocks tailored to their strategies, enhancing decision-making and potentially improving returns.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
GE HealthCare (Nasdaq: GEHC) will present at the Jefferies Global Healthcare Conference on November 18, 2025. A webcast will be available on their investor website.
Why It Matters
Management presentations at investor conferences can signal company strategy and performance insights, influencing investor sentiment and stock price movements for GE HealthCare.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Investors considering Medical - Products stocks should compare GE HealthCare Technologies (GEHC) and EssilorLuxottica Unsponsored ADR (ESLOY) for potential undervaluation.
Why It Matters
The comparison between GE HealthCare Technologies and EssilorLuxottica highlights potential investment opportunities in undervalued stocks within the medical products sector, influencing portfolio decisions.
Source: Zacks Investment Research
Market Sentiment:
Positive
Tariffs Bite Into GE HealthCare Q3 Profit Margin
16 days ago
Quick Summary
GE HealthCare (NYSE:GEHC) reported Q3 2025 adjusted earnings of $1.07 per share, surpassing the consensus estimate of $1.05.
Why It Matters
GE HealthCare's earnings beat expectations, indicating strong performance and potential for growth, which may boost investor confidence and the stock's value.
Source: Benzinga
Market Sentiment:
Negative
Quick Summary
GE HealthCare Technologies raised its annual adjusted profit forecast and exceeded Q3 estimates, driven by strong demand for medical devices in the U.S. and EMEA regions.
Why It Matters
GE HealthCare's raised profit forecast and strong Q3 results indicate robust demand, signaling potential growth and stability, which can positively impact investor sentiment and stock performance.
Source: Reuters
Market Sentiment:
Positive
GE HealthCare Tech Profit Slides as Tariffs Drag
17 days ago
Quick Summary
GE HealthCare Technologies reported a profit decline in Q3, attributed to increased costs from tariffs.
Why It Matters
Falling profits due to tariff costs may signal rising operational challenges for GE HealthCare, potentially affecting future earnings and stock performance.
Source: WSJ
Market Sentiment:
Negative
Frequently Asked Questions About GEHC Stock
What is GE HealthCare Technologies Inc.'s (GEHC) stock forecast for 2026?
Based on our analysis of 20 Wall Street analysts, GE HealthCare Technologies Inc. (GEHC) has a median price target of $87.00. The highest price target is $108.00 and the lowest is $73.00.
Is GEHC stock a good investment in 2026?
According to current analyst ratings, GEHC has 15 Buy ratings, 7 Hold ratings, and 0 Sell ratings. The stock is currently trading at $73.15. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for GEHC stock?
Wall Street analysts predict GEHC stock could reach $87.00 in the next 12 months. This represents a 18.9% increase from the current price of $73.15. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is GE HealthCare Technologies Inc.'s business model?
The company generates revenue by designing, manufacturing, and distributing medical imaging systems, patient monitoring devices, and digital health technologies. By providing essential equipment and solutions to hospitals, clinics, and research institutions, it supports healthcare professionals in improving diagnostics and patient care.
What is the highest forecasted price for GEHC GE HealthCare Technologies Inc.?
The highest price target for GEHC is $108.00 from at , which represents a 47.6% increase from the current price of $73.15.
What is the lowest forecasted price for GEHC GE HealthCare Technologies Inc.?
The lowest price target for GEHC is $73.00 from Graham Doyle at UBS, which represents a -0.2% decrease from the current price of $73.15.
What is the overall GEHC consensus from analysts for GE HealthCare Technologies Inc.?
The overall analyst consensus for GEHC is bullish. Out of 20 Wall Street analysts, 15 rate it as Buy, 7 as Hold, and 0 as Sell, with a median price target of $87.00.
How accurate are GEHC stock price projections?
Stock price projections, including those for GE HealthCare Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 15, 2025 2:57 AM UTC